PHS
SLB icon

PFM Health Sciences’s SLB Ltd SLB Stock Holding History

PFM Health Sciences’s Portfolio SLB Stock Details SLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-549,389
Closed -$42.9M – 109
2017
Q1 		$42.9M Buy
+549,389
New +$44.9M 1.07% 37
2013
Q3 		– Sell
-443,645
Closed -$31.8M – 87
2013
Q2 		$31.8M Buy
+443,645
New +$32.8M 0.66% 37

Other funds holding SLB

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PFM Health Sciences's SLB Position: Q2 2017 in Review

PFM Health Sciences sold out of SLB Ltd (SLB) in Q2 2017, closing a stake of 549,389 shares — an estimated $42.9M sold.

PFM Health Sciences first reported a position in SLB in Q2 2013 and held it in 2 quarters. The position peaked at $42.9M in Q1 2017. 1,595 funds tracked by Wall St. Rank hold SLB as of Q2 2017.

  • PFM Health Sciences reported no remaining SLB Ltd position as of Q2 2017 after selling out during the quarter.
  • PFM Health Sciences sold 549,389 SLB Ltd shares in Q2 2017, an estimated $42.9M.
  • PFM Health Sciences first reported a position in SLB Ltd in Q2 2013 and held it in 2 quarters.
  • PFM Health Sciences's SLB Ltd position peaked at $42.9M in Q1 2017.
  • 1,595 funds tracked by Wall St. Rank held SLB Ltd as of Q2 2017.

Based on PFM Health Sciences's 13F filing for Q2 2017, filed 14 Aug 2017.